The novel osimertinib resistant lung cancer mice model harboring EGFR mutations driven by the SP-C promoter

被引：1
|
作者：
Ohashi, Kadoaki [1 ]
Higo, Hisao [2 ]
Makimoto, Go [2 ]
Kudo, Kenichiro [3 ]
Nishii, Kazuya [2 ]
Ninomiya, Kiichiro [2 ]
Kayatani, Hiroe [2 ]
Ninomiya, Takashi [1 ]
Kubo, Toshio [1 ]
Rai, Kammei [1 ]
Ichihara, Eiki [1 ]
Hotta, Katsuyuki [1 ]
Tabata, Masahiro [1 ]
Kiura, Katsuyuki [1 ]
机构：
[1] Okayama Univ Hosp, Okayama, Japan
[2] Okayama Univ, Okayama, Japan
[3] NHO Iwakuni Med Ctr, Okayama, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1160
引用
收藏
页数：2
相关论文
共 44 条
  • [1] Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter
    Ohashi, Kadoaki
    Rai, Kammei
    Fujiwara, Yoshiro
    Osawa, Masahiro
    Hirano, Seiki
    Takata, Katsuyoshi
    Kondo, Eisaku
    Yoshino, Tadashi
    Takata, Minoru
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. CANCER SCIENCE, 2008, 99 (09) : 1747 - 1753
  • [2] Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review
    Zhao, Yuanyuan
    Zhai, Linzhu
    Deng, Lei
    Halmos, Balazs
    Cheng, Haiying
    [J]. CLINICAL LUNG CANCER, 2021, 22 (03) : E466 - E469
  • [3] Tumor immunoediting in a lung cancer mouse model harboring EGFR mutations
    Nishii, Kazuya
    Ohashi, Kadoaki
    Ninomiya, Kiichiro
    Makimoto, Go
    Watanabe, Hiromi
    Kano, Hirohisa
    Hara, Naofumi
    Udono, Heiichiro
    Kiura, Katsuyuki
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] SP-C gene mutations and lung fibrosis: a novel form of conformational disease
    Stevens, PA
    Witt, H
    Beers, MF
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 : 59S - 60S
  • [5] Transgenic glucocorticoid receptor expression driven by the SP-C promoter reduces neonatal lung cellularity and midkine expression in GRhypo mice
    Gagnon, Stephane
    Atmodjo, Wayhuni
    Humes, Daryl
    McKerlie, Colin
    Kaplan, Feige
    Sweezey, Neil B.
    [J]. BIOLOGY OF THE NEONATE, 2006, 90 (01): : 46 - 57
  • [6] Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations
    Yang, Guang-Jian
    Li, Jun
    Xu, Hai-Yan
    Sun, Yang
    Liu, Liu
    Li, Hong-Shuai
    Yang, Lu
    Zhang, Yuan
    Li, Guo-Hui
    Wang, Yan
    [J]. LUNG CANCER, 2021, 152 : 39 - 48
  • [7] Drug Tolerant Persister Cells to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer Harboring EGFR Mutations (NORA)
    Lee, J. B.
    Choi, S. J.
    Park, Y. J.
    Park, K. -H.
    Yong, S. H.
    Shim, H. S.
    Park, B. J.
    Lee, C. Y.
    Cheung, S. K.
    Sudhaman, S.
    Velichko, S.
    Krainock, M.
    Sethi, H.
    Liu, M. C.
    Hong, M. H.
    Cho, B. C.
    Lim, S. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S140 - S141
  • [8] Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer
    Roper, Nitin
    El Meskini, Rajaa
    Maity, Tapan
    Atkinson, Devon
    Day, Amanda
    Pate, Nathan
    Cultraro, Constance M.
    Pack, Svetlana
    Zgonc, Valerie
    Ohler, Zoe Weaver
    Guha, Udayan
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 337 - 348
  • [9] Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids
    Notter, Robert H.
    Gupta, Rohun
    Schwan, Adrian L.
    Wang, Zhengdong
    Shkoor, Mohanad Gh
    Walther, Frans J.
    [J]. PEERJ, 2016, 4
  • [10] SP-C driven transgenic glucocorticoid receptor (GR) reduces neonatal lung cellularity in GRhypo,hypo (knockout) mice
    Gagnon, S
    Atmodjo, W
    Humes, D
    Kaplan, F
    Sweezey, NB
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 35A - 35A
12345